Medicis Pharmaceutical Corp. (MRX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $75.71 +1.77%
EPS Growth %: +27.1%
Financial Fact:
Basic net income (loss) per share: 0.02
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +27.1%
Financial Fact:
Basic net income (loss) per share: 0.02
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q3 EPS of $0.96, $0.02 better than the analyst estimate of $0.94. Revenue for the quarter came in at $484.6 million versus the consensus estimate of $475.84 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Brookfield prices $600M senior notes at 5.65% due 2031
- Cematrix wins $8.8M in new contracts, bringing YTD total to $43.2M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
